HIGH-DOSE CISPLATIN - PHASE-I-II STUDY

被引：0
|
作者：
BRUNETTI, I
MERLANO, M
GRIMALDI, A
BENEDETTI, G
GARAVENTA, G
MODENESI, M
ROSSO, R
机构：
[1] IST NAZL RIC CANC, Genoa, ITALY
[2] OSPED CIVILI, DIV OTORHINOLARYNGOL, Genoa, ITALY
来源：
TUMORI JOURNAL | 1986年 / 72卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：691 / 691
页数：1
相关论文
共 50 条
  • [21] PHASE-I-II STUDY OF CONTINUOUS-INFUSION HIGH-DOSE HUMAN-LYMPHOBLASTOID INTERFERON AND THE INVITRO SENSITIVITY OF LEUKEMIC PROGENITORS IN NONLYMPHOCYTIC LEUKEMIA
    MIRRO, J
    DOW, LW
    KALWINSKY, DK
    DAHL, GV
    WECK, P
    WHISNANT, J
    MURPHY, SB
    CANCER TREATMENT REPORTS, 1986, 70 (03): : 363 - 367
  • [22] A PHASE-I-II STUDY OF HIGH-DOSE N,N',N''-TRIETHYLENETHIOPHOSPHORAMIDE (THIO-TEPA) AND AUTOLOGOUS MARROW TRANSPLANTATION (AMT) FOR REFRACTORY MALIGNANCIES
    HERZIG, R
    BROWN, R
    FAY, J
    WOLFF, S
    EGORIN, M
    STRANDJORD, S
    KRUPP, K
    HERZIG, G
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 256 - 256
  • [23] REPEATED HIGH-DOSE MELPHALAN + AUTOLOGOUS MARROW TRANSPLANTATIONS (HDM + AMT) IN ADVANCED SOLID TUMORS (ST) AND LEUKEMIA IN RELAPSE - PHASE-I-II STUDY
    MARANINCHI, D
    GASTAUT, JA
    ABECASIS, MA
    SEBAHOUN, G
    DOMINGUEZ, C
    NOVAKOVITCH, G
    CARCASSONNE, Y
    EXPERIMENTAL HEMATOLOGY, 1983, 11 : 170 - 170
  • [24] PHASE-I-II STUDY OF HIGH-DOSE MELPHALAN AND AUTOLOGOUS MARROW TRANSPLANTATION IN ADULT PATIENTS WITH POOR-RISK NON-HODGKINS LYMPHOMAS
    MASCRET, B
    MARANINCHI, D
    GASTAUT, JA
    BAUME, D
    SEBAHOUN, G
    LEJEUNE, C
    NOVAKOVITCH, G
    SAINTY, D
    HORCHOWSKI, N
    TUBIANA, N
    CARCASSONNE, Y
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (03) : 216 - 221
  • [25] PHASE-I-II TRIAL OF ERYTHROPOIETIN IN THE TREATMENT OF CISPLATIN-ASSOCIATED ANEMIA
    MILLER, CB
    PLATANIAS, LC
    MILLS, SR
    ZAHURAK, ML
    RATAIN, MJ
    ETTINGER, DS
    JONES, RJ
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (02) : 98 - 103
  • [26] PHASE-II TRIAL OF HIGH-DOSE CISPLATIN IN PATIENTS WITH MALIGNANT MESOTHELIOMA
    MINTZER, DM
    KELSEN, D
    FRIMMER, D
    HEELAN, R
    GRALLA, R
    CANCER TREATMENT REPORTS, 1985, 69 (06): : 711 - 712
  • [27] Phase II study of high-dose dexamethasone-based association in acute and delayed high-dose cisplatin-induced emesis – JCOG study 9413
    I Sekine
    Y Nishiwaki
    R Kakinuma
    K Kubota
    F Hojo
    T Matsumoto
    H Ohmatsu
    M Yokozaki
    K Goto
    T Miyamoto
    J Takafuji
    T Kodama
    British Journal of Cancer, 1997, 76 : 90 - 92
  • [28] ADVANCED PANCREATIC-CANCER - A PHASE I-II TRIAL OF CISPLATIN, HIGH-DOSE CYTARABINE, AND CAFFEINE
    DOUGHERTY, JB
    KELSEN, D
    KEMENY, N
    MAGILL, G
    BOTET, J
    NIEDZWIECKI, D
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (22) : 1735 - 1738
  • [29] PHASE-I-II TRIAL OF PRERADIATION HIGH-DOSE INTRAVENOUS METHOTREXATE CHEMOTHERAPY FOR NEWLY DIAGNOSED MALIGNANT CHILDHOOD BRAIN-TUMORS
    ALLEN, JC
    WALKER, R
    ROSEN, G
    ANNALS OF NEUROLOGY, 1986, 20 (03) : 424 - 425
  • [30] INTRACAVITARY PHASE-I-II METHOTREXATE
    CONROY, T
    WEBER, B
    GUILLEMIN, F
    KRAKOWSKI, I
    LUPORSI, E
    METZ, R
    BULLETIN DU CANCER, 1986, 73 (04) : 430 - 430
12345